Piramal Recalls Sevoflurane Inhalation Anesthetic Due to pH Failure
Piramal Critical Care is recalling 12,600 bottles of Sevoflurane inhalation anesthetic because the product was too acidic, failing pH specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to a pH specification failure (product too acidic). Per the rubric, this falls under 'Minor labeling errors, low-risk contamination, voluntary precautionary recalls' as no specific injuries or illnesses are reported in the source text, and the defect is a chemical specification deviation rather than a high-risk pathogen or structural defect.
Plain-English summary
Piramal Critical Care, Inc. is recalling 12,600 bottles of Sevoflurane, USP (Inhalation Anesthetic), 250 mL Amber Bottle. The recall is due to the product failing pH specifications, specifically being too acidic. The affected product is a prescription-only medication manufactured by Piramal Critical Care, Inc., located in Bethlehem, PA.
The recall covers seven specific lots: S2611I28, S2511I14, S2531I16, S2721J21, S2871K03, S2881K03, and S2931K07. These lots have expiration dates ranging from September 2016 to November 2016. The product was distributed to wholesale distributors and retailers located nationwide.
Healthcare providers and consumers should stop using the affected lots of Sevoflurane and contact Piramal Critical Care, Inc. for further instructions or a return. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- SEVOFLURANE (SEVOFLURANE)
- Brand
- SEVOFLURANE
- Manufacturer
- Piramal Critical Care, Inc.
- Category
- Drug — Inhalation Anesthetic
- Affected units
- 12,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: S2611I28 (exp 9/16)
- S2511I14 (exp 9/16)
- S2531I16 (exp 9/16)
- S2721J21 (exp 10/16)
- S2871K03 (exp 11/16)
- S2881K03 (exp 11/16)
- and S2931K07 (exp 11/16).
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SEVOFLURANE
- ModerateBaxter Recalls Sevoflurane Inhalation Anesthetic Due to Failed Stability Specifications
FDA (Drugs) · 2019-06-19
Same manufacturer · Piramal Critical Care, Inc.
See all →- ModerateRocuronium Bromide Injection Lacks Paralyzing Agent Warning
FDA (Drugs) · 2021-10-27
- ModeratePiramal Recalls Gablofen Baclofen Injection Due to Unknown Impurity
FDA (Drugs) · 2019-08-07
Same hazard · ph failure
See all →- ModerateDiclofenac topical gel recalled after failing pH specifications
FDA (Drugs) · 2026-01-28
- LowFerring Recalls Menopur Due to Out-of-Specification pH in Diluent
FDA (Drugs) · 2021-03-17
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-12-23
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-11-25